Cargando…
Mobile PSA: A Novel Telehealth Tool for Prostate Cancer Follow-Up
The prevalence of prostate cancer (PCa) is increasing. As the prognosis of PCa continues to improve, the increasing follow-up requirements after radical prostatectomy or radiotherapy puts significant pressure on health care systems. Follow-up is typically conducted by treating urologists, specialize...
Autores principales: | Bergroth, Robin, Matikainen, Mika, Rannikko, Antti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317875/ https://www.ncbi.nlm.nih.gov/pubmed/34337524 http://dx.doi.org/10.1016/j.euros.2021.04.004 |
Ejemplares similares
-
Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023) -
Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation
por: Singh, Zorawar, et al.
Publicado: (2022) -
Telehealth use and perceptions among prostate cancer survivors
por: Chen, Luke W., et al.
Publicado: (2023) -
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes
por: Qaoud, Yazan, et al.
Publicado: (2020) -
Does Protocol Make a Difference? Comparison of Two Prostate Cancer Active Surveillance Cohorts: A Non–protocol-based Follow-up and a Protocol-based Contemporary Follow-up
por: Kalalahti, Inari, et al.
Publicado: (2021)